您當前的位置：檢測資訊 > 行業研究
嘉峪檢測網 2023-06-07 09:59
| 公開/公告號 | US8129622B2 | 申請日 | 2009/5/21 |
| 發明名稱 | Insulator for feedthrough | ||
| 解決的技術問題 | Construction of a feedthrough assembly can require the use of forming weights, complicating production, and in some instances, limiting the minimum feedthrough size. In addition, some insulating members are susceptible to reaction with aqueous solutions, such as body fluids. Reaction with body fluids can erode the insulating member and diminish performance over time. It is desirable to develop improved feedthroughs for IMDs. | ||
| 技術方案 | A hermetically sealed microelectromechanical system (MEMS) package for an implantable medical device is presented. The MEMS comprises a first substrate that includes an aperture. A feedthrough assembly is coupled to the aperture; the feedthrough assembly comprises a conductive element housed in a glass insulating member. A second substrate is coupled to the first substrate. | ||
| 相關附圖 |
 |
||
| 公開/公告號 | US7824805B2 | 申請日 | 2007/1/17 |
| 發明名稱 | Implantable medical device battery | ||
| 解決的技術問題 | Implantable medical devices (IMDs) detect and deliver therapy for a variety of medical conditions in patients. IMDs include implantable pulse generators (IPGs) or implantable cardioverter-defibrillators (ICDs) that deliver electrical stimuli to tissue of a patient. ICDs typically comprise, inter alia, a control module, a capacitor, and a battery that are housed in a hermetically sealed container. When therapy is required by a patient, the control module signals the battery to charge the capacitor, which in turn discharges electrical stimuli to tissue of a patient. | ||
| 技術方案 | A battery cell in an implantable medical device is presented. The battery cell includes an anode, a cathode, an insulator therebetween, and an electrolyte. The cathode includes silver vanadium oxide and fluorinated carbon (CFx). The CFx includes fluorine at greater than or equal to 61 percentage (%) by weight. | ||
| 相關附圖 |
 |
||
| 公開/公告號 | US8295939B2 | 申請日 | 2011/5/17 |
| 發明名稱 | Programmer for biostimulator system | ||
| 解決的技術問題 | Known pulse generators can include various sensors for estimating metabolic demand, to enable an increase in pacing rate proportional and appropriate for the level of exercise. The function is usually known as rate-responsive pacing. For example, an accelerometer can measure body motion and indicate activity level. A pressure transducer in the heart can sense the timing between opening and closing of various cardiac valves, or can give a measure of intracardiac pressure directly, both of which change with changing stroke volume. Stroke volume increases with increased activity level. A temperature sensor can detect changes in a patient's blood temperature, which varies based on activity level. The pacemaker can increase rate proportional to a detected increase in activity. | ||
| 技術方案 | A biostimulator system comprises one or more implantable devices and an external programmer configured for communicating with the implantable device or devices via bidirectional communication pathways comprising a receiving pathway that decodes information encoded on stimulation pulses generated by ones of the implantable device or devices and conducted through body tissue to the external programmer. | ||
| 相關附圖 |
 |
||
| 公開/公告號 | US8958892B2 | 申請日 | 2013/11/19 |
| 發明名稱 | Delivery catheter systems and methods | ||
| 解決的技術問題 | Although more than one hundred thousand conventional cardiac pacing systems are implanted annually, various well-known difficulties exist, of which a few will be cited. For example, a pulse generator, when located subcutaneously, presents a bulge in the skin that patients can find unsightly, unpleasant, or irritating, and which patients can subconsciously or obsessively manipulate or “twiddle”. Even without persistent manipulation, subcutaneous pulse generators can exhibit erosion, extrusion, infection, and disconnection, insulation damage, or conductor breakage at the wire leads. Although sub-muscular or abdominal placement can address some concerns, such placement involves a more difficult surgical procedure for implantation and adjustment, which can prolong patient recovery. | ||
| 技術方案 | A delivery system for implanting a leadless cardiac pacemaker into a patient is provided. The cardiac pacemaker can include a docking or delivery feature having a through-hole disposed on or near a proximal end of the pacemaker for attachment to the delivery system. In some embodiments, the delivery catheter can include first and second tethers configured to engage the delivery feature of the pacemaker. The tethers, when partially aligned, can have a cross-sectional diameter larger than the through-hole of the delivery feature, and when un-aligned, can have a cross-sectional diameter smaller than the through-hole of the delivery feature. Methods of delivering the leadless cardiac pacemaker with the delivery system are also provided. | ||
| 相關附圖 |
 |
||
來源：醫械知識產權
